Dmytruk Mark E. 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Dmytruk Mark E.
See remarks
Transactions
- Conversion
Class A Common Stock
2025-03-13+9,497→ 44,149 total - Conversion
Class B Common Stock
2025-03-13−9,497→ 5,914 total→ Class A Common Stock (9,497 underlying)
Footnotes (2)
- [F1]Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
- [F2]Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.